Remember though. Relief has 0 assets above the patents and intellectual property. So now. If someone wants to buy out Aviptadil for 3 billion dollars. Do you think GEM will play fair and take 2 billion and split the rest with the shareholders? Or would they take 3 billion, sell the intellectual property which includes the rights to the current trials and keep 3b for themselves? And convert relief into a shell company that’s just an ad-rev based .com landing page. This is now the reality of this game. Does GEM play fair or not.
News 
Market Data 
Discover 
AI
